Welcome : Guest

Akari Therapeutics Plc (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Akari Therapeutics Plc, which is principally involved in Biopharmaceuticals Business. Illustrated with 18 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-63989
Price: $900
Company Type: Public
Pages: 20
Date: November 2016
Market Data Tables: 18

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Specialty Pharma & Orphan Drugs......3
Table 1: Specialty Pharma & Orphan Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, US and Rest of the World......3
Ophthalmic Drugs......4
Table 2: Ophthalmic Antibiotic Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Besivance, Moxeza, Vigamox, Zymaxid and Generic & Others......4
Table 3: Ophthalmic Steroid Drug Market in the US (2015) - Percentage Market Share Breakdown by Value for Alrex, Durezol, Lotemax, Ozurdex and Generic & Others......5
Inflammatory Bowel Disease (IBD)......6
Table 4: Inflammatory Bowel Disease (IBD) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Anti-Inflammatory, Biologics, and Immunomodulatory......6
Oncology/Hematology Drugs......7
Table 5: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......7
Neurology......8
Table 6: Neurology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Cerebrospinal Fluid Management, Interventional Neuroradiology, Neurostimulation, Neurosurgery, and Neurovascular Catheters......8
Kidney Disease Drugs......9
Table 7: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2015) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......9
Table 8: Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......10
Table 9: Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, EPO alfa/beta biosimilars and Others......11
Table 10: Hemodialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Mircera)......12
Table 11: Chronic Kidney Disease Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp and Others......13
Table 12: Peritoneal Dialysis Market by Drug in the US (2015) - Percentage Share Breakdown by Value Sales for Aranesp, Epogen, and Others (Includes Mircera)......14
Table 13: New Patients with Kidney Failure by Cause in the US (2015) - Percentage Share Breakdown by Volume for Diabetes, High Blood Pressure and Others......15
Orphan Disease Therapeutics......16
Table 14: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......16
Ophthalmology Drugs......17
Table 15: Market Shares of Leading Ophthalmology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for F. Hoffmann-La Roche AG, Merck Ltd., Novartis AG, Pfizer, Inc., and Others......17
Table 16: Market Shares of Leading Ophthalmic Steroids Brands in the US (2015) - Percentage Share Breakdown by Value for Fluorometholone, Lotemax, Prednisolone and Others......18
Anti-Inflammatory Biologics......19
Table 17: Market Shares of Leading Anti-Inflammatory Biologic Brands Worldwide (2015) - Percentage Share Breakdown by Value for Actemra, Enbrel, Humira, Remicade and Other......19
Onc./Hematology Therapeutics......20
Table 18: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......20